CGON
Price
$37.77
Change
-$1.64 (-4.16%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
3.01B
5 days until earnings call
Intraday BUY SELL Signals
RVMD
Price
$64.37
Change
-$1.46 (-2.22%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
12.73B
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs RVMD

Header iconCGON vs RVMD Comparison
Open Charts CGON vs RVMDBanner chart's image
CG Oncology
Price$37.77
Change-$1.64 (-4.16%)
Volume$17.52K
Capitalization3.01B
Revolution Medicines
Price$64.37
Change-$1.46 (-2.22%)
Volume$42.67K
Capitalization12.73B
CGON vs RVMD Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. RVMD commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and RVMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CGON: $39.41 vs. RVMD: $65.83)
Brand notoriety: CGON and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 68% vs. RVMD: 121%
Market capitalization -- CGON: $3.01B vs. RVMD: $12.73B
CGON [@Biotechnology] is valued at $3.01B. RVMD’s [@Biotechnology] market capitalization is $12.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RVMD is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 3 bullish TA indicator(s).

  • CGON’s TA Score: 4 bullish, 5 bearish.
  • RVMD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both CGON and RVMD are a bad buy in the short-term.

Price Growth

CGON (@Biotechnology) experienced а +3.82% price change this week, while RVMD (@Biotechnology) price change was +10.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

CGON is expected to report earnings on Nov 18, 2025.

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($12.7B) has a higher market cap than CGON($3.01B). RVMD YTD gains are higher at: 50.503 vs. CGON (37.413). CGON has higher annual earnings (EBITDA): -157.09M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. CGON (661M). CGON has less debt than RVMD: CGON (994K) vs RVMD (133M). CGON has higher revenues than RVMD: CGON (551K) vs RVMD (0).
CGONRVMDCGON / RVMD
Capitalization3.01B12.7B24%
EBITDA-157.09M-883.71M18%
Gain YTD37.41350.50374%
P/E RatioN/AN/A-
Revenue551K0-
Total Cash661M2.14B31%
Total Debt994K133M1%
TECHNICAL ANALYSIS
Technical Analysis
CGONRVMD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 7 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 23 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGIBX42.650.30
+0.71%
MFS International Intrinsic Value B
MMOJX10.190.06
+0.59%
MassMutual Overseas Y
MCRFX15.310.07
+0.46%
BlackRock Mid-Cap Value Investor C
GGSOX16.090.02
+0.12%
Grandeur Peak Global Stalwarts Investor
FRESX39.03N/A
N/A
Fidelity Real Estate Investment Port

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+1.47%
NUVL - CGON
59%
Loosely correlated
+0.91%
SYRE - CGON
58%
Loosely correlated
+0.34%
IDYA - CGON
58%
Loosely correlated
-0.19%
ACLX - CGON
58%
Loosely correlated
-0.09%
KYMR - CGON
55%
Loosely correlated
+0.25%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+2.73%
NUVL - RVMD
62%
Loosely correlated
+0.91%
OCUL - RVMD
53%
Loosely correlated
+2.41%
NRIX - RVMD
53%
Loosely correlated
-5.37%
CGON - RVMD
52%
Loosely correlated
+1.47%
ROIV - RVMD
52%
Loosely correlated
+2.01%
More